EMEA (Europe, Middle East and Africa) Combination Vaccine Market Report 2017

December 2017 | 105 pages | ID: EE49AD14BD3EN
QYResearch

Abstracts

In this report, the EMEA Combination Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Combination Vaccine for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Combination Vaccine market competition by top manufacturers/players, with Combination Vaccine sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• GSK
• Sanofi Pasteur
• Merck
• Pfizer
• CNBG
• Sanofi Pasteur MSD
• Serum Institute of India
• Biokangtai

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Meningococcal Vaccine
• Japanese Encephalitis Vaccine
• Yellow Fever Vaccine
• Hepatitis Vaccine
• Cholera Vaccine
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Adults
• Children

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Combination Vaccine Market Report 2017

1 COMBINATION VACCINE OVERVIEW

1.1 Product Overview and Scope of Combination Vaccine
1.2 Classification of Combination Vaccine
  1.2.1 EMEA Combination Vaccine Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Combination Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Meningococcal Vaccine
  1.2.4 Japanese Encephalitis Vaccine
  1.2.5 Yellow Fever Vaccine
  1.2.6 Hepatitis Vaccine
  1.2.7 Cholera Vaccine
  1.2.8 Other
1.3 EMEA Combination Vaccine Market by Application/End Users
  1.3.1 EMEA Combination Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Adults
  1.3.3 Children
1.4 EMEA Combination Vaccine Market by Region
  1.4.1 EMEA Combination Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Combination Vaccine (2012-2022)
  1.5.1 EMEA Combination Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Combination Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA COMBINATION VACCINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Combination Vaccine Market Competition by Players/Manufacturers
  2.1.1 EMEA Combination Vaccine Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Combination Vaccine Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Combination Vaccine Sale Price by Players (2012-2017)
2.2 EMEA Combination Vaccine (Volume and Value) by Type/Product Category
  2.2.1 EMEA Combination Vaccine Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Combination Vaccine Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Combination Vaccine Sale Price by Type (2012-2017)
2.3 EMEA Combination Vaccine (Volume) by Application
2.4 EMEA Combination Vaccine (Volume and Value) by Region
  2.4.1 EMEA Combination Vaccine Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Combination Vaccine Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Combination Vaccine Sales Price by Region (2012-2017)

3 EUROPE COMBINATION VACCINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Combination Vaccine Sales and Value (2012-2017)
  3.1.1 Europe Combination Vaccine Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Combination Vaccine Revenue and Growth Rate (2012-2017)
3.2 Europe Combination Vaccine Sales and Market Share by Type
3.3 Europe Combination Vaccine Sales and Market Share by Application
3.4 Europe Combination Vaccine Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Combination Vaccine Sales Volume by Countries (2012-2017)
  3.4.2 Europe Combination Vaccine Revenue by Countries (2012-2017)
  3.4.3 Germany Combination Vaccine Sales and Growth Rate (2012-2017)
  3.4.4 France Combination Vaccine Sales and Growth Rate (2012-2017)
  3.4.5 UK Combination Vaccine Sales and Growth Rate (2012-2017)
  3.4.6 Russia Combination Vaccine Sales and Growth Rate (2012-2017)
  3.4.7 Italy Combination Vaccine Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Combination Vaccine Sales and Growth Rate (2012-2017)

4 MIDDLE EAST COMBINATION VACCINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Combination Vaccine Sales and Value (2012-2017)
  4.1.1 Middle East Combination Vaccine Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Combination Vaccine Revenue and Growth Rate (2012-2017)
4.2 Middle East Combination Vaccine Sales and Market Share by Type
4.3 Middle East Combination Vaccine Sales and Market Share by Application
4.4 Middle East Combination Vaccine Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Combination Vaccine Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Combination Vaccine Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Combination Vaccine Sales and Growth Rate (2012-2017)
  4.4.4 Israel Combination Vaccine Sales and Growth Rate (2012-2017)
  4.4.5 UAE Combination Vaccine Sales and Growth Rate (2012-2017)
  4.4.6 Iran Combination Vaccine Sales and Growth Rate (2012-2017)

5 AFRICA COMBINATION VACCINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Combination Vaccine Sales and Value (2012-2017)
  5.1.1 Africa Combination Vaccine Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Combination Vaccine Revenue and Growth Rate (2012-2017)
5.2 Africa Combination Vaccine Sales and Market Share by Type
5.3 Africa Combination Vaccine Sales and Market Share by Application
5.4 Africa Combination Vaccine Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Combination Vaccine Sales Volume by Countries (2012-2017)
  5.4.2 Africa Combination Vaccine Revenue by Countries (2012-2017)
  5.4.3 South Africa Combination Vaccine Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Combination Vaccine Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Combination Vaccine Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Combination Vaccine Sales and Growth Rate (2012-2017)

6 EMEA COMBINATION VACCINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Combination Vaccine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GSK Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi Pasteur
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Combination Vaccine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi Pasteur Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Combination Vaccine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Combination Vaccine Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 CNBG
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Combination Vaccine Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 CNBG Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sanofi Pasteur MSD
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Combination Vaccine Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sanofi Pasteur MSD Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Serum Institute of India
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Combination Vaccine Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Serum Institute of India Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Biokangtai
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Combination Vaccine Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Biokangtai Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 COMBINATION VACCINE MANUFACTURING COST ANALYSIS

7.1 Combination Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Combination Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Combination Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Combination Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA COMBINATION VACCINE MARKET FORECAST (2017-2022)

11.1 EMEA Combination Vaccine Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Combination Vaccine Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Combination Vaccine Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Combination Vaccine Price and Trend Forecast (2017-2022)
11.2 EMEA Combination Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Combination Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Combination Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Combination Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Combination Vaccine Sales Forecast by Type (2017-2022)
11.7 EMEA Combination Vaccine Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Combination Vaccine
Figure EMEA Combination Vaccine Sales Volume (Units) by Type (2012-2022)
Figure EMEA Combination Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Meningococcal Vaccine Product Picture
Figure Japanese Encephalitis Vaccine Product Picture
Figure Yellow Fever Vaccine Product Picture
Figure Hepatitis Vaccine Product Picture
Figure Cholera Vaccine Product Picture
Figure Other Product Picture
Figure EMEA Combination Vaccine Sales Volume (Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Combination Vaccine by Application in 2016
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Children Examples
Table Key Downstream Customer in Children
Figure EMEA Combination Vaccine Market Size (Million USD) by Region (2012-2022)
Figure Europe Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Combination Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Combination Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Combination Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Combination Vaccine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Combination Vaccine Market Major Players Product Sales Volume (Units) (2012-2017)
Table EMEA Combination Vaccine Sales Volume (Units) of Major Players (2012-2017)
Table EMEA Combination Vaccine Sales Share by Players (2012-2017)
Figure 2016 Combination Vaccine Sales Share by Players
Figure 2017 Combination Vaccine Sales Share by Players
Figure EMEA Combination Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Combination Vaccine Revenue (Million USD) by Players (2012-2017)
Table EMEA Combination Vaccine Revenue Share by Players (2012-2017)
Table 2016 EMEA Combination Vaccine Revenue Share by Players
Table 2017 EMEA Combination Vaccine Revenue Share by Players
Table EMEA Combination Vaccine Sale Price (K USD/Unit) by Players (2012-2017)
Table EMEA Combination Vaccine Sales (Units) and Market Share by Type (2012-2017)
Table EMEA Combination Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Combination Vaccine by Type (2012-2017)
Figure EMEA Combination Vaccine Sales Market Share by Type (2012-2017)
Table EMEA Combination Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Combination Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Combination Vaccine by Type in 2016
Table EMEA Combination Vaccine Sale Price (K USD/Unit) by Type (2012-2017)
Table EMEA Combination Vaccine Sales (Units) and Market Share by Application (2012-2017)
Table EMEA Combination Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Combination Vaccine by Application (2012-2017)
Figure EMEA Combination Vaccine Sales Market Share by Application in 2016
Table EMEA Combination Vaccine Sales (Units) and Market Share by Region (2012-2017)
Table EMEA Combination Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Combination Vaccine by Region (2012-2017)
Figure EMEA Combination Vaccine Sales Market Share in 2016
Table EMEA Combination Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Combination Vaccine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Combination Vaccine by Region (2012-2017)
Figure EMEA Combination Vaccine Revenue Market Share Regions in 2016
Table EMEA Combination Vaccine Sales Price (K USD/Unit) by Region (2012-2017)
Figure Europe Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Europe Combination Vaccine Revenue and Growth Rate (2012-2017)
Table Europe Combination Vaccine Sales (Units) by Type (2012-2017)
Table Europe Combination Vaccine Market Share by Type (2012-2017)
Figure Europe Combination Vaccine Market Share by Type in 2016
Table Europe Combination Vaccine Sales (Units) by Application (2012-2017)
Table Europe Combination Vaccine Market Share by Application (2012-2017)
Figure Europe Combination Vaccine Market Share by Application in 2016
Table Europe Combination Vaccine Sales (Units) by Countries (2012-2017)
Table Europe Combination Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Combination Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Combination Vaccine Sales Market Share by Countries in 2016
Table Europe Combination Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Europe Combination Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Combination Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Combination Vaccine Revenue Market Share by Countries in 2016
Figure Germany Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure France Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure UK Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Russia Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Italy Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Benelux Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Combination Vaccine Sales (Units) by Type (2012-2017)
Table Middle East Combination Vaccine Market Share by Type (2012-2017)
Figure Middle East Combination Vaccine Market Share by Type (2012-2017)
Table Middle East Combination Vaccine Sales (Units) by Applications (2012-2017)
Table Middle East Combination Vaccine Market Share by Applications (2012-2017)
Figure Middle East Combination Vaccine Sales Market Share by Application in 2016
Table Middle East Combination Vaccine Sales Volume (Units) by Countries (2012-2017)
Table Middle East Combination Vaccine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Combination Vaccine Sales Volume Market Share by Countries in 2016
Table Middle East Combination Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Combination Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Combination Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Combination Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Israel Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure UAE Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Iran Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Africa Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Africa Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Combination Vaccine Sales (Units) by Type (2012-2017)
Table Africa Combination Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Combination Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Combination Vaccine Sales Market Share by Type in 2016
Table Africa Combination Vaccine Sales (Units) by Application (2012-2017)
Table Africa Combination Vaccine Sales Market Share by Application (2012-2017)
Figure Africa Combination Vaccine Sales Market Share by Application (2012-2017)
Table Africa Combination Vaccine Sales Volume (Units) by Countries (2012-2017)
Table Africa Combination Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Combination Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Combination Vaccine Sales Market Share by Countries in 2016
Table Africa Combination Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Africa Combination Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Combination Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Combination Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Nigeria Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Egypt Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Algeria Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Table GSK Combination Vaccine Basic Information List
Table GSK Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure GSK Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure GSK Combination Vaccine Sales Market Share in EMEA (2012-2017)
Figure GSK Combination Vaccine Revenue Market Share in EMEA (2012-2017)
Table Sanofi Pasteur Combination Vaccine Basic Information List
Table Sanofi Pasteur Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Pasteur Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Sanofi Pasteur Combination Vaccine Sales Market Share in EMEA (2012-2017)
Figure Sanofi Pasteur Combination Vaccine Revenue Market Share in EMEA (2012-2017)
Table Merck Combination Vaccine Basic Information List
Table Merck Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Merck Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Merck Combination Vaccine Sales Market Share in EMEA (2012-2017)
Figure Merck Combination Vaccine Revenue Market Share in EMEA (2012-2017)
Table Pfizer Combination Vaccine Basic Information List
Table Pfizer Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Pfizer Combination Vaccine Sales Market Share in EMEA (2012-2017)
Figure Pfizer Combination Vaccine Revenue Market Share in EMEA (2012-2017)
Table CNBG Combination Vaccine Basic Information List
Table CNBG Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure CNBG Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure CNBG Combination Vaccine Sales Market Share in EMEA (2012-2017)
Figure CNBG Combination Vaccine Revenue Market Share in EMEA (2012-2017)
Table Sanofi Pasteur MSD Combination Vaccine Basic Information List
Table Sanofi Pasteur MSD Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Pasteur MSD Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Sanofi Pasteur MSD Combination Vaccine Sales Market Share in EMEA (2012-2017)
Figure Sanofi Pasteur MSD Combination Vaccine Revenue Market Share in EMEA (2012-2017)
Table Serum Institute of India Combination Vaccine Basic Information List
Table Serum Institute of India Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Serum Institute of India Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Serum Institute of India Combination Vaccine Sales Market Share in EMEA (2012-2017)
Figure Serum Institute of India Combination Vaccine Revenue Market Share in EMEA (2012-2017)
Table Biokangtai Combination Vaccine Basic Information List
Table Biokangtai Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Biokangtai Combination Vaccine Sales (Units) and Growth Rate (2012-2017)
Figure Biokangtai Combination Vaccine Sales Market Share in EMEA (2012-2017)
Figure Biokangtai Combination Vaccine Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Combination Vaccine
Figure Manufacturing Process Analysis of Combination Vaccine
Figure Combination Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Combination Vaccine Major Manufacturers in 2016
Table Major Buyers of Combination Vaccine
Table Distributors/Traders List
Figure EMEA Combination Vaccine Sales (Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Combination Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Combination Vaccine Price (K USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Combination Vaccine Sales (Units) Forecast by Region (2017-2022)
Figure EMEA Combination Vaccine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Combination Vaccine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Combination Vaccine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Combination Vaccine Sales (Units) Forecast by Countries (2017-2022)
Figure Europe Combination Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Combination Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Combination Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Combination Vaccine Sales (Units) Forecast by Countries (2017-2022)
Figure Middle East Combination Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Combination Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Combination Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Combination Vaccine Sales (Units) Forecast by Countries (2017-2022)
Figure Africa Combination Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Combination Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Combination Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Combination Vaccine Sales (Units) Forecast by Type (2017-2022)
Figure EMEA Combination Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Combination Vaccine Sales (Units) Forecast by Application (2017-2022)
Figure EMEA Combination Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources